Vaccine
Access to innovation in prevention and early detection
3 questions to Colleen Kamrad - Vice President & General Manager GSK, Switzerland
Our commitment in the special situation - diagnostics, medicines, vaccines
Three questions to Nicholas Franco from Johnson & Johnson